Takeshi Tojo

1.1k total citations
21 papers, 839 citations indexed

About

Takeshi Tojo is a scholar working on Pathology and Forensic Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Takeshi Tojo has authored 21 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 7 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Takeshi Tojo's work include Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Systemic Lupus Erythematosus Research (7 papers). Takeshi Tojo is often cited by papers focused on Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Systemic Lupus Erythematosus Research (7 papers). Takeshi Tojo collaborates with scholars based in Japan, United States and United Kingdom. Takeshi Tojo's co-authors include Mitsuo Homma, Junichi Kaburaki, Masataka Kuwana, Yutaka Okano, Masashi Akizuki, Hajime Yamagata, George J. Friou, Masataka Kuwana, Thomas A. Medsger and Yutaka Kawakami and has published in prestigious journals such as Science, FEBS Letters and The Journal of Arthroplasty.

In The Last Decade

Takeshi Tojo

21 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Tojo Japan 13 482 285 252 219 132 21 839
Beatriz Joven Spain 14 311 0.6× 338 1.2× 212 0.8× 272 1.2× 38 0.3× 40 761
Theodora E. Markatseli Greece 14 243 0.5× 366 1.3× 149 0.6× 277 1.3× 48 0.4× 36 739
L Origgi Italy 11 248 0.5× 175 0.6× 73 0.3× 148 0.7× 33 0.3× 23 511
T. Kinoshita Japan 11 372 0.8× 61 0.2× 108 0.4× 176 0.8× 61 0.5× 26 761
Vasiliki-Kalliopi Bournia Greece 15 223 0.5× 255 0.9× 73 0.3× 114 0.5× 111 0.8× 35 589
Éric Rich Canada 13 749 1.6× 397 1.4× 368 1.5× 308 1.4× 25 0.2× 17 1.2k
Andreu Fernández‐Codina Spain 13 374 0.8× 279 1.0× 307 1.2× 128 0.6× 29 0.2× 43 710
Gabór Kumánovics Hungary 13 328 0.7× 107 0.4× 131 0.5× 138 0.6× 50 0.4× 31 551
Rafael G. Grau United States 7 303 0.6× 109 0.4× 77 0.3× 82 0.4× 48 0.4× 8 500
Gemma Lepri Italy 15 585 1.2× 112 0.4× 139 0.6× 162 0.7× 29 0.2× 24 720

Countries citing papers authored by Takeshi Tojo

Since Specialization
Citations

This map shows the geographic impact of Takeshi Tojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Tojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Tojo more than expected).

Fields of papers citing papers by Takeshi Tojo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Tojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Tojo. The network helps show where Takeshi Tojo may publish in the future.

Co-authorship network of co-authors of Takeshi Tojo

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Tojo. A scholar is included among the top collaborators of Takeshi Tojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Tojo. Takeshi Tojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuwana, Masataka, et al.. (2000). Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. Arthritis & Rheumatism. 43(5). 1074–1074. 98 indexed citations
2.
Hanyu, Tadamasa, Akira Murasawa, & Takeshi Tojo. (1997). Survivorship analysis of total knee arthroplasty with the kinematic prosthesis in patients who have rheumatoid arthritis. The Journal of Arthroplasty. 12(8). 913–919. 21 indexed citations
3.
Yokoyama, Masako, Akira Suwa, Takao Fujii, et al.. (1995). A case of adult onset Still's disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation.. Japanese Journal of Clinical Immunology. 18(2). 207–214. 19 indexed citations
4.
Kaburaki, Junichi, Masataka Kuwana, Masashi Akizuki, Makoto Takano, & Takeshi Tojo. (1995). Efficacy of beraprost sodium on Raynaud's phenomenon in patients with systemic sclerosis.. Japanese Journal of Clinical Immunology. 18(1). 29–35. 3 indexed citations
5.
6.
Kuwana, Masataka, Yutaka Okano, Junichi Kaburaki, Takeshi Tojo, & Thomas A. Medsger. (1994). Racial differences in the distribution of systemic sclerosis–related serum antinuclear antibodies. Arthritis & Rheumatism. 37(6). 902–906. 101 indexed citations
7.
Kuwana, Masataka, Junichi Kaburaki, Yutaka Okano, Takeshi Tojo, & Mitsuo Homma. (1994). Clinical and Prognostic Associations Based on Serum Antinuclear Antibodies in Japanese Patients with Systemic Sclerosis. Arthritis & Rheumatism. 37(1). 75–83. 217 indexed citations
8.
Tsuzaka, Kensei, Takao Fujii, Masashi Akizuki, et al.. (1994). Clinical Significance of Antibodies to Native or Denatured 60‐kd or 52‐kd Ro/SS‐A Proteins in Sjögren's Syndrome. Arthritis & Rheumatism. 37(1). 88–92. 26 indexed citations
9.
Kuwana, Masataka, Junichi Kaburaki, Tsuneyo Mimori, Takeshi Tojo, & Mitsuo Homma. (1993). Autoantigenic epitopes on dna topoisomerase i. Arthritis & Rheumatism. 36(10). 1406–1413. 35 indexed citations
10.
Nagai, Masaki, Tomio Hirohata, Yoshifuji Matsumoto, et al.. (1993). A case control study of female systemic lupus erythematosus in Japan. European Journal of Public Health. 3(3). 172–176. 6 indexed citations
11.
Kaburaki, Junichi, et al.. (1992). Specificity of Antibodies to Single-stranded(ss) DNA in SLE Patients with Anti-phospholipid Syndrome.. The Keio Journal of Medicine. 41(1). 10–15. 6 indexed citations
12.
Kaburaki, Junichi, et al.. (1992). Initial Predictors of Survival in Patients with Systemic Sclerosis (Scleroderma).. The Keio Journal of Medicine. 41(3). 141–145. 17 indexed citations
13.
Sasamura, Hiroyuki, Hidetomo Nakamoto, Shinichi Abe, et al.. (1991). Repeated Intestinal Ulcerations in a Patient With Systemic Lupus Erythematosus and High Serum Antiphospholipid Antibody Levels. Southern Medical Journal. 84(4). 515–517. 5 indexed citations
14.
Kaburaki, Junichi, et al.. (1991). Quality of life(QOL) in patients with systemic sclerosis.. Japanese Journal of Clinical Immunology. 14(6). 626–632. 1 indexed citations
15.
Homma, Mitsuo, Takeshi Tojo, Masashi Akizuki, & Hajime Yamagata. (1986). Criteria for Sjögren’s Syndrome in Japan. Scandinavian Journal of Rheumatology. 15(sup61). 26–27. 134 indexed citations
16.
Yamagata, Hajime, Masashi Akizuki, Takeshi Tojo, & Mitsuo Homma. (1986). Anti-Ro/SSA and -La/SSB Antibodies in Patients with Connective Tissue Diseases. Scandinavian Journal of Rheumatology. 15(sup61). 98–101. 20 indexed citations
17.
Samuels, D. Scott, Takeshi Tojo, Mitsuo Homma, & Nobuyoshi Shimizu. (1986). Inhibition of topoisomerase I by antibodies in sera from scleroderma patients. FEBS Letters. 209(2). 231–234. 11 indexed citations
18.
Kaburaki, Junichi, et al.. (1981). Autoantibodies in scleroderma. Ensho. 1(5). 607–613. 1 indexed citations
19.
Kobayashi, Yoshio, Takeshi Tojo, Tohru Abe, et al.. (1977). PROGRESSIVE SYSTEMIC SCLEROSIS SINE SCLERODERMA WITH NEPHROTIC SYNDROME AND SUSPECTED RENAL TUBULAR ACIDOSIS. Nihon Naika Gakkai Zasshi. 66(2). 186–192. 1 indexed citations
20.
Tojo, Takeshi, Kozo HAMAGUCHI, Michiko Imanishi, & T Amano. (1966). Structure of Lysozyme. The Journal of Biochemistry. 60(5). 538–542. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Joven Breakdown of academic impact, for papers by Theodora E. Markatseli Breakdown of academic impact, for papers by L Origgi Breakdown of academic impact, for papers by T. Kinoshita Breakdown of academic impact, for papers by Vasiliki-Kalliopi Bournia Breakdown of academic impact, for papers by Éric Rich Breakdown of academic impact, for papers by Andreu Fernández‐Codina Breakdown of academic impact, for papers by Gabór Kumánovics Breakdown of academic impact, for papers by Rafael G. Grau Breakdown of academic impact, for papers by Gemma Lepri
Rankless by CCL
2026